About 772,496 results


E25Bio has designed lateral flow rapid detection tests for fever viruses that can deliver results as little as five minutes and up to 15. Our tests are being designed to work immediately with no moving parts, no machinery, and provide a visual readout. We aim to change the way we diagnose disease and help prevent pandemics.

We test a home antibody kit for tracking Covid-19

Home testing kits will likely be an important part of monitoring Covid-19. Swab tests can tell whether a person is currently infected, while antibody tests look for signs of past infection. But before tests like these are rolled out, researchers need to make sure they're reliable and easy for people to use at home. We gave one of the home testing kits a go, and spoke to researcher Christina Atc...

A Cheap, Simple Way to Control the Coronavirus

Simple at-home tests for the coronavirus, some that involve spitting into a small tube of solution, could be the key to expanding testing and impeding the spread of the pandemic. The Food and Drug Administration should encourage their development and then fast track approval.

FBI Warns of Potential Fraud in Antibody Testing for COVID-19

The Federal Bureau of Investigation is warning the public about potential fraud schemes related to antibody tests for COVID-19.

Chilblain acral lesions in the COVID‐19 era. Are they marker of infection in asymptomatic patients?

During these months in which the COVID‐19 emergency is waning, the activity of dermatologists has changed substantially. Since the beginning of March 2020, in the Dermatology Clinic at the University Hospital in Turin (Italy), the outpatient access has been significantly reduced and telemedicine has been useful whenever possible, by putting the patient in contact directly with dermatologists or...

Recommendations to Optimize the Safety of Elective Surgical Care While Limiting the Spread of COVID-19: Primum Non Nocere

COVID-19 has drastically altered our lives in an unprecedented manner, shuttering industries and leaving most of the country in isolation as we adapt to the evolving crisis. Orthopedic surgery has not been spared from these effects, with the postponement of elective procedures in an attempt to mitigate disease transmission and preserve hospital resources as the pandemic continues to expand. Dur...

Why Only Test Symptomatic Patients? Consider Random Screening for COVID‑19

The world is at war with the coronavirus disease 2019 (COVID-19) pandemic. With many places still facing a drastic shortage of testing resources, what is the best way to deploy these scarce tests? In the United States (US), the Center for Disease Control and Prevention (CDC) implemented strict criteria that a patient needed to satisfy to qualify for testing, including (1) physical symptoms ...

Exploring Drug Repurposing for COVID-19 Treatment

It usually takes more than a decade to develop a safe, effective anti-viral therapy. But, when it comes to coronavirus disease 2019 (COVID-19), we don’t have that kind of time. One way to speed the process may be to put some old drugs to work against this new disease threat. This is generally referred to as “drug repurposing.” NIH has been doing everything possible to encourage screens of ex...

SARS-CoV-2 Reference Panel Comparative Data

The FDA SARS-CoV-2 Reference Panel allows for a more precise comparison of the analytical performance of different molecular in vitro diagnostic (IVD) assays intended to detect SARS-CoV-2. The Reference Panel contains common, independent, and well-characterized reference material that is available to developers of SARS-CoV-2 nucleic acid-based amplification tests (NAATs) for which Emergency Use...

Comparison of nasopharyngeal and oropharyngeal swabs for SARS-CoV-2 detection in 353 patients received tests with both specimens simultaneously
International Journal of Infectious Diseases;

Since the outbreak of coronavirus disease (COVID-19) in Wuhan in December 2019, by March 10, 2020, a total of 80,932 confirmed cases have been reported in China. Two consecutively negative RTPCR test results in respiratory tract specimens is required for the evaluation of discharge from hospital, and oropharyngeal swabs were the most common sample. However, false negative results occurred in ...

Evaluating and Testing Persons for Coronavirus Disease 2019 (COVID-19)

Clinicians considering diagnostic testing of people with possible COVID-19 should continue to work with their local and state health departments to coordinate testing through public health laboratories, or work with commercial or clinical laboratories using diagnostic tests authorized for emergency use by the U.S. Food and Drug Administration.

Serology Testing for COVID-19 at CDC

CDC has developed a laboratory blood test to assist with efforts to determine how much of the U.S. population has been infected with SARS-CoV-2, the virus that causes COVID-19. CDC is also using its serologic test (antibody) to evaluate the performance of commercial antibody tests.

Interim Guidelines for COVID-19 Antibody Testing

Serologic methods have been developed and will have important public health and clinical uses to monitor and respond to the COVID-19 pandemic.

CDC Diagnostic Test for COVID-19

CDC has developed a new laboratory test kit for use in testing patient specimens for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19. The test kit is called the “Centers for Disease Control and Prevention (CDC) 2019-Novel Coronavirus (2019-nCoV) Real-Time Reverse Transcriptase (RT)-PCR Diagnostic Panel.” It is intended for use with the Applied Biosys...

Widespread Impact of COVID-19 on Cancer Research and Treatment

May 29th, 2020 - There is no doubt that the COVID-19 pandemic has negatively affected cancer research and patient treatment worldwide. ASCO addressed this during the ASCO20 Virtual Scientific Program during the session, “Cancer Care in the Time of COVID: Assessing Impact and Future Directions.” The session began with an overview given by Norman E. Sharpless, MD, director of the National Cancer Institute (NCI). ...

Screening for Drug Use in Primary Care: Practical Implications of the New USPSTF Recommendation

The US Preventive Services Task Force (USPSTF) now recommends screening for unhealthy drug use if effective treatment is available (B recommendation), which is an update to its 2008 conclusion of insufficient information.1 The new recommendation is based on 3 important findings from large bodies of research in adults. First, valid screening tests for drug use are available. Second, treatments f...

Effects of Equal Volume Heavy-Resistance Strength Training Versus Strength Endurance Training on Physical Fitness and Sport-Specific Performance in Young Elite Female Rowers

Strength training is an important means for performance development in young rowers. The purpose of this study was to examine the effects of a 9-week equal volume heavy-resistance strength training (HRST) versus strength endurance training (SET) in addition to regular rowing training on primary (e.g., maximal strength/power) and secondary outcomes (e.g., balance) in young rowers. Twenty-six fem...

Beware of False-Positive Results with SARS-CoV-2 Antibody Tests

‘Breakthrough’ COVID-19 Tests Are Currently Cheap, Fast—and Not Very Accurate

An inexpensive coronavirus test that millions of Americans could use at a pharmacy, in a workplace or even at home could prove to be a vital asset in allowing people to return to jobs and school.

Why are coronavirus tests so difficult to produce?

Despite how crucial testing is, some countries have far more tests than others – and that testing isn’t available to everyone. The reason comes down to several factors, including timing, logistics, and the complexity of collecting samples, obtaining the raw materials and equipment for testing, and having the expertise to do the tests accurately.